Evidence map›Paper›PMID 20653641›Full record

Trial reportThe American journal on addictions

Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment.

Ari D Kalechstein, Richard De La Garza, Thomas F Newton

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal on addictions. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2011
    Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Modafinil, an atypical CNS stimulant?Advances in pharmacology (San Diego, Calif.) · 2024
    Article
  9. Methamphetamine Toxicities and Clinical Management.NEJM evidence · 2023 · on this map
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Prefrontal cortex executive processes affected by stress in health and disease.Progress in neuro-psychopharmacology & biological psychiatry · 2018
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ari D KalechsteinMenninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas 77030, USA. ari.kalechstein@bcm.tmc.edu
Richard De La Garza
Thomas F Newton
Baylor College of Medicine · US

Funding

ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
An ACE Inhibitor as a Treatment for Methamphetamine DependenceR01DA023468 · NIDA · BAYLOR COLLEGE OF MEDICINE · PI NEWTON, THOMAS FREDERICK · 2008 to 2012
$1.9M
Assess of Stress Effects in Methamphetamine DependenceK24DA017754 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI NEWTON, THOMAS FREDERICK · 2005 to 2010
$727k
Methamphetamine Dependence: Treating Cognition DisorderR03DA020591 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KALECHSTEIN, ARI D · 2005 to 2005
$77k
NCRR NIH HHS M01 RR000865NCRR NIH HHS RR00865NIDA NIH HHS K24 DA017754NIDA NIH HHS K24DA017754NIDA NIH HHS R01 DA023468NIDA NIH HHS R03 DA020591NIDA NIH HHS R03DA020591-01
6 · The paper itself

Abstract

Modafinil improves working memory in healthy subjects and individuals diagnosed with schizophrenia and Attention Deficit/Hyperactivity Disorder, though the effects of modafinil have not been evaluated on working memory in methamphetamine-dependent subjects. This double-blind, placebo-controlled study evaluated whether a daily dose of 400 mg of modafinil, administered over three consecutive days, would enhance performance on a measure of working memory relative to test performance at baseline and following 3 days of placebo administration in 11 methamphetamine addicted, nontreatment-seeking volunteers. The results revealed that participants demonstrating relatively poor performance on the third day of a 3-day washout period (ie, at baseline), showed significant improvement on measures of working memory, but not on measures of episodic memory or information processing speed. In contrast, for participants demonstrating relatively high performance at baseline, modafinil administration did not affect test scores. The findings provide an initial indication that modafinil can reverse methamphetamine-associated impairments in working memory.

Indexed as

AdolescentAdultAmphetamine-Related DisordersBenzhydryl CompoundsCentral Nervous System StimulantsFemaleHumansMemory, Short-TermMental RecallMiddle AgedModafinilNeuropsychological TestsBenzhydryl CompoundsCentral Nervous System StimulantsModafinil

Identifiers

PMID20653641
PMCPMC3341927
OpenAlexW1558666780

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.